Abivax S.A. (ABVX)
NASDAQ: ABVX
· Real-Time Price · USD
72.44
0.55 (0.77%)
At close: Aug 21, 2025, 11:23 AM
Abivax S.A. Income Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 7.4M | 3.39M | 2.33M | 2.25M | 2.25M | 2.23M | n/a | n/a |
Cost of Revenue | n/a | n/a | 378K | 329K | 32K | 39K | 124K | 32K |
Gross Profit | 7.4M | 3.39M | 2.33M | 2.25M | 2.25M | 2.23M | -124K | -32K |
Operating Income | -132.99M | -40M | -92.46M | -39.53M | -38.8M | -18.63M | -25.69M | -26.53M |
Interest Income | n/a | n/a | n/a | n/a | 113K | 15K | 84K | n/a |
Pretax Income | -135.42M | -40.82M | -98.05M | -54.19M | -42.55M | -31.77M | -27.42M | -18.14M |
Net Income | -94.6M | -40.82M | -95.79M | -51.95M | -40.29M | -29.55M | -24.83M | -16.53M |
Selling & General & Admin | 16.74M | 22.16M | 21.53M | 6.58M | 5.27M | 2.22M | 2.3M | 2.45M |
Research & Development | 81.88M | 32.33M | 70.55M | 32.62M | 32.84M | 15.11M | 23.25M | 23.95M |
Other Expenses | 41.76M | -28K | n/a | -7K | -1K | 10.93M | -17K | -96K |
Operating Expenses | 140.38M | 43.39M | 92.08M | 39.21M | 37.99M | 28.26M | 25.56M | 26.5M |
Interest Expense | n/a | n/a | 5.7M | 14.7M | 1.81M | 2.13M | 2.18M | 1.03M |
Selling & Marketing Expenses | 1.73M | 2.11M | 5.9M | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 140.38M | 43.39M | 92.46M | 39.53M | 38.02M | 18.63M | 25.69M | 26.53M |
Income Tax Expense | n/a | n/a | -2.26M | -2.23M | -2.26M | -2.22M | -2.59M | -1.61M |
Shares Outstanding (Basic) | 63.17M | 62.92M | 48.29M | 35.9M | 22.3M | 16.77M | 16.76M | 14.66M |
Shares Outstanding (Diluted) | 63.17M | 62.92M | 48.29M | 35.9M | 22.3M | 16.77M | 16.76M | 14.66M |
EPS (Basic) | -0.75 | -0.65 | -1.98 | -1.45 | -1.81 | -1.76 | -1.48 | -1.13 |
EPS (Diluted) | -0.75 | -0.65 | -1.98 | -1.45 | -1.81 | -1.76 | -1.48 | -1.13 |
EBITDA | -46.03M | -39.91M | -92.08M | -39.21M | -36.15M | -15.02M | -25.56M | -26.5M |
EBIT | -92.99M | -40M | -92.34M | -39.49M | -36.19M | -15.05M | -25.24M | -26.52M |
Depreciation & Amortization | 464.5K | 85.5K | 378K | 329K | 32K | 39K | 124K | 32K |